期刊文献+

黄芪平甲方联合他巴唑治疗老年性甲状腺功能亢进症42例 被引量:6

Clinical Research of 42 Cases of Senile Hyperthyroidism Treated with Huang Qi Ping Jia Foumula
下载PDF
导出
摘要 目的:观察黄芪平甲方联合他巴唑治疗老年性甲状腺功能亢进症的疗效。方法:分析72例老年性甲状腺功能亢进症和30例中青年性甲状腺功能亢进症患者各自临床特点;并将72例老年甲亢患者随机分为2组,治疗组42例,在对照组基础上加用黄芪平甲方治疗,对照组30例,单用西药治疗。结果:治疗后两组甲状腺激素水平相比无显著性差异(P>0.05),治疗组较对照组可减少药物不良反应,缩短疗程,降低复发率。结论:黄芪平甲方联合他巴唑治疗老年性甲状腺功能亢进症效果满意。 Objective:To observe the efficacy of Huang Qi Ping Jia Foumula in treating senile hyperthyroidism.Method:Collect clinical features of 72 cases of hyperthyroidism,and 30 cases of young and middle aged patients and 72 cases of elderly patients with hyperthyroidism were randomly divided into treatment group and control group;treatment group was given combined Chinese and Western medicine treatment and the control group was given western medicine alone.Results:After treatment,the levels of thyroid hormones in the two groups had no significant difference(P〉0.05);compared with the control group,the treatment group can reduce adverse drug reactions,shorten the course of treatment and reduce the relapse rate.Conclusion:Huang Qi Ping Jia Foumula has satisfactory effect in senile hyperthyroidism.
作者 丁继存
出处 《中医学报》 CAS 2010年第2期290-291,共2页 Acta Chinese Medicine
关键词 甲状腺功能亢进症 老年性 黄芪平甲方 他巴唑 hyperthyroidism senile huang qi ping jia foumulas methimazole
  • 相关文献

参考文献3

  • 1郑筱萸.中药新药临床研究指导原则(试行)[S].北京:中国医药科技出版社,2005.89.
  • 2陈可冀,主编.老年人甲状腺功能亢进[M].北京:中国医药科技出版社,1999.194~195.
  • 3李如兰.浅述含碘中药治疗瘿瘤的合理应用[J].实用中医药杂志,2001,17(8):47-47. 被引量:7

共引文献14

同被引文献58

  • 1向平,易岂建.病毒性心肌炎发病机理及黄芪免疫干预作用研究进展[J].儿科药学杂志,2005,11(3):10-12. 被引量:8
  • 2刘东方,邓华聪,许改平,侯平,雄波.自身免疫性甲状腺疾病血IL-1β与PBMC抗原的关系[J].天津医药,2005,33(8):476-478. 被引量:1
  • 3刘幼硕.老年人甲状腺功能亢进症[J].中华老年医学杂志,2005,24(11):878-880. 被引量:17
  • 4陆再英,钟南山,主编.内科学[M].第7版.北京:人民卫生出版社,2007.282.
  • 5Fisfalen ME, Soliman M, Okamoto Y, et al. Proliferative responses of T-cells to thyroid antigens and synthetic thyroid peroxidase peptides in autoimmune thyroid disease [ J ]. J Clin Endocrinol Metab, 1995, 80(5): 1597-1604.
  • 6Diez JJ, Hernanz A, Mdeina S, et al. Serum concentration of tumor necrosis factor 2 alpha and soluble TNF2 alpha re- ceptor p55 in patients with hypothyroidism and hyperthy- roidism after normalization of thyroid function[ J]. Clin En- docrinol (Oxf) , 2002, 57(4): 515-521.
  • 7Zantut-Wittmann DE, Tambascia MA, da Silva Trevisan MA, et al. Anti-thyroid drugs inhibit in vivo HLA2DR ex- pression in thyroid follicular cells in Graves disease [ J ]. Thyroid, 2001, 11(6) : 575 -580.
  • 8Arao T, Morimoto T, Kakinuma A, et al. Thyrocyte prolif- eration by cellular adhesion infiltrating lymphocytes through the intercellular adhesion molecule-Hymphocyte function- associated antigen-1 pathway in Graves disease[ J]. J Clin Endocrinol Metab, 2000, 85 ( 1 ) : 382 - 389.
  • 9Ajjan RA, Weetman AP. Cytokines in thyroid autoimmuni- ty [ J ]. Autoimmunity, 2003, 36 (6 - 7) : 351 - 359.
  • 10Kouki Mori, Katsumi Yoshida, Ayumi Komatsu, et al. Au- toinduction of tumor necrosis factor-co in FRTL-5 rat thyroid cells[J]. J Endocrinol, 2005, 187(1): 17 -24.

引证文献6

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部